Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback